The survey study estimated that, during a one-month period, over 15 million U.S. adults took supplements containing ...

Detailed price information for Y-Mabs Therapeutics Inc (YMAB-Q) from The Globe and Mail including charting and trades.

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and ...

Dermatologists like Rossi think people can skip showers altogether, multiple days per week. This view isn’t unanimous, though ...

Headache relief is different for everyone, but you can try compresses, massage, lying down, and sipping tea. Learn how to get ...

Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization ...